Direct Modification of Extracellular Vesicles and Its Applications for Cancer Therapy: A Mini-Review

被引:16
作者
Nan, Wenbin [1 ,2 ]
Zhang, Chao [1 ]
Wang, Hao [1 ]
Chen, Hongli [1 ,2 ]
Ji, Shenglu [1 ]
机构
[1] Xinxiang Med Univ, Coll Life Sci & Technol, Nano Biomed Mat Res Ctr, Xinxiang, Peoples R China
[2] Xinxiang Med Univ, Hosp 3, Xinxiang, Peoples R China
来源
FRONTIERS IN CHEMISTRY | 2022年 / 10卷
基金
中国国家自然科学基金;
关键词
extracellular vesicles; cancer therapy; drug delivery; modification; nanomedicine; TARGETING DELIVERY; BLOOD EXOSOMES; NANOPARTICLES; ALARMIN; RNA;
D O I
10.3389/fchem.2022.910341
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Extracellular vesicles (EVs) are a class of lipid membrane-bound vesicles released by various cells and mediate cell-to-cell communication. By reason of their high physiochemical stability and biocompatibility, EVs are considered as novel drug delivery system. An increasing number of studies have indicated that EVs can be modified to enhance their loading efficiency, targeting ability and therapeutic capabilities for cancer therapy. Compared with the tedious process of gene engineering approaches, direct modification of EVs is easier, faster and versatile. This mini review will summarize the prevailing approaches for direct modification of EVs. Additionally, the potential applications of modified EVs in cancer therapy are also discussed, which will help readers gain a better understanding of the technologies and applications in this field.
引用
收藏
页数:7
相关论文
共 63 条
[1]   scFv Antibody: Principles and Clinical Application [J].
Ahmad, Zuhaida Asra ;
Yeap, Swee Keong ;
Ali, Abdul Manaf ;
Ho, Wan Yong ;
Alitheen, Noorjahan Banu Mohamed ;
Hamid, Muhajir .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
[2]   Mechanisms of acquired tumor drug resistance [J].
Aleksakhina, Svetlana N. ;
Kashyap, Aniruddh ;
Imyanitov, Evgeny N. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1872 (02)
[3]   Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents [J].
Bose, Rajendran J. C. ;
Kumar, Sukumar Uday ;
Zeng, Yitian ;
Afjei, Rayhaneh ;
Robinson, Elise ;
Lau, Kenneth ;
Bermudez, Abel ;
Habte, Frezghi ;
Pitteri, Sharon J. ;
Sinclair, Robert ;
Willmann, Juergen K. ;
Massoud, Tarik F. ;
Gambhir, Sanjiv S. ;
Paulmurugan, Ramasamy .
ACS NANO, 2018, 12 (11) :10817-10832
[4]   Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy [J].
Cao, Yu ;
Wu, Tingting ;
Zhang, Kai ;
Meng, Xiangdan ;
Dai, Wenhao ;
Wang, Dongdong ;
Dong, Haifeng ;
Zhang, Xueji .
ACS NANO, 2019, 13 (02) :1499-1510
[5]   Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy [J].
Cheng, Hong ;
Fan, Jing-Hao ;
Zhao, Lin-Ping ;
Fan, Gui-Ling ;
Zheng, Rong-Rong ;
Qiu, Xiao-Zhong ;
Yu, Xi-Yong ;
Li, Shi-Ying ;
Zhang, Xian-Zheng .
BIOMATERIALS, 2019, 211 :14-24
[6]   Manufacturing Exosomes: A Promising Therapeutic Platform [J].
Colao, Ivano Luigi ;
Corteling, Randolph ;
Bracewell, Daniel ;
Wall, Ivan .
TRENDS IN MOLECULAR MEDICINE, 2018, 24 (03) :242-256
[7]   A History of Cancer Chemotherapy [J].
DeVita, Vincent T., Jr. ;
Chu, Edward .
CANCER RESEARCH, 2008, 68 (21) :8643-8653
[8]   Functionalized DNA Enables Programming Exosomes/Vesicles for Tumor Imaging and Therapy [J].
Fan, Zhijin ;
Xiao, Keng ;
Lin, Jingyan ;
Liao, Yuhui ;
Huang, Xi .
SMALL, 2019, 15 (47)
[9]   CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity [J].
Fu, Wenyan ;
Lei, Changhai ;
Liu, Shuowu ;
Cui, Yingshu ;
Wang, Chuqi ;
Qian, Kewen ;
Li, Tian ;
Shen, Yafeng ;
Fan, Xiaoyan ;
Lin, Fangxing ;
Ding, Min ;
Pan, Mingzhu ;
Ye, Xuting ;
Yang, Yongji ;
Hu, Shi .
NATURE COMMUNICATIONS, 2019, 10 (1)
[10]   Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins [J].
Fuhrmann, Gregor ;
Serio, Andrea ;
Mazo, Manuel ;
Nair, Rekha ;
Stevens, Molly M. .
JOURNAL OF CONTROLLED RELEASE, 2015, 205 :35-44